<html xmlns="http://www.w3.org/1999/xhtml"><body><table class="table"><caption /><tr><th class="cell">Study type (CONSORT/STROBE) </th><th class="cell">Main cancer class </th><th class="cell">CIPN severity report (count by grade if given) </th><th class="cell">CIPN assessment time points </th><th class="cell">CIPN assessment method(s) </th></tr><tr><td class="cell">Oxaliplatin: 72.3% (95% CI = 59.7–86.8)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Antonacopoulou</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">NR</td><td class="cell">Unclear</td><td class="cell">TNSc</td></tr><tr><td class="cell">(2009) ^{*}</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Argyriou (2007) [8]</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">Grade I (6/16)</td><td class="cell">Baseline</td><td class="cell">TNSc</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (8/16)</td><td class="cell">Cycles 4, 8, 12</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (2/16)</td><td class="empty"></td><td class="cell">NCI-CTC</td></tr><tr><td class="cell">Argyriou (2012)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">Grade I (38/125)</td><td class="cell">Baseline</td><td class="cell">TNSc</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (46/125)</td><td class="cell">Cycles 3, 6 (FOLFOX)</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (41/125)</td><td class="cell">Cycles 4, 8 (XELOX)</td><td class="cell">NCI-CTC</td></tr><tr><td class="cell">Argyriou (2013) ^{†}</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">Grade I (62/169)</td><td class="cell">Baseline</td><td class="cell">TNSc</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (46/169)</td><td class="cell">Cycle 6, 12 (FOLFOX)</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (61/169)</td><td class="cell">Cycles 4, 8 (XELOX)</td><td class="empty"></td></tr><tr><td class="cell">Attal (2009)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">Sensory symptom counts</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">described as means/</td><td class="cell">Cycle 3, 6, 9</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">individual</td><td class="cell">12 ± 2 mo after chemo end</td><td class="cell">(EORTC) QLQ-C30</td></tr><tr><td class="cell">Cascinu (2002)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Colorectal</td><td class="cell">Grade I (4/15)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (6/15)</td><td class="cell">Cycles 4, 8, 12</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (4/15)</td><td class="cell">Within 2 wk of chemo end</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade IV (1/15)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Gobran (2013)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Colorectal</td><td class="cell">Grade I (7/21)</td><td class="cell">Unclear if at baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (0/21)</td><td class="cell">At each chemo cycle until end of chemo</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">(variable no. of cycles)</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (14/21)</td><td class="cell">Longer follow-up for those with CIPN (but</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">denominator unclear)</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade IV (0/21)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Ishibashi (2010)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Colorectal</td><td class="cell">Grade I (15/15)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (1/15)</td><td class="cell">At each chemo cycle until end of chemo</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (0/15)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade IV (0/15)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Krishnan (2005)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">NR</td><td class="cell">No baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Within 1 mo of chemo end only reported</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">assessment</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">TNSc</td></tr><tr><td class="cell">Lin (2006)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Controlled trial</td><td class="cell">Colorectal</td><td class="cell">Grade I (1/9)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (5/9)</td><td class="cell">Cycles 4, 8, 12</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (3/9)</td><td class="cell">Within 2 wk of end of chemo</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade IV (0/9)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Milla (2009)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Controlled trial</td><td class="cell">Colorectal</td><td class="cell">Grade I (0/13)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (9/13)</td><td class="cell">Cycles 5, 9, 12</td><td class="cell">NES</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (4/13)</td><td class="cell">(Some followed up longer but denominator</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">unclear)</td><td class="empty"></td></tr><tr><td class="cell">Won (2012)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Colorectal</td><td class="cell">NR</td><td class="cell">Unclear if at baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">At each chemo cycle until end of chemo</td><td class="cell">NES</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">(variable no. of cycles)</td><td class="empty"></td></tr><tr><td class="cell">Cisplatin: 42.2% (95% CI = 21.3–63.1)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Argyriou (2006) ^{‡}</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Prospective cohort</td><td class="cell">Lung</td><td class="cell">Reported by age group</td><td class="cell">Baseline</td><td class="cell">PNS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">only</td><td class="cell">Cycles 3, 6</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">3 mo after chemo end</td><td class="empty"></td></tr><tr><td class="cell">Cascinu (1995)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Gastrointestinal</td><td class="cell">Grade I (3/16)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (10/16)</td><td class="cell">After 9 and 15 wk of therapy</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (2/16)</td><td class="cell">Within 1 wk after end of chemo</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade IV (1/16)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Gandara (1995)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Ovarian and</td><td class="cell">Only grade P3 reported</td><td class="cell">Unclear if at baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="cell">lung</td><td class="empty"></td><td class="cell">At each cycle until chemo end (variable no. of</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">cycles)</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Study stopped early after interim analysis due</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">to high toxicity in intervention group</td><td class="empty"></td></tr><tr><td class="cell">Kemp (1996)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Gynecological</td><td class="cell">Grade I (31/81)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (35/81)</td><td class="cell">Cycles 4, 5, 6</td><td class="cell">NES</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III (15/81)</td><td class="cell">Monthly after chemo for 3 mo</td><td class="empty"></td></tr><tr><td class="cell">Pace (2003)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Controlled trial</td><td class="cell">Multiple solid</td><td class="cell">Grade I (6/12)</td><td class="cell">Baseline</td><td class="cell">TNSc</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade II (4/12)</td><td class="cell">After 6 cycles</td><td class="cell">NES</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Grade III &amp; IV (2/12)</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Pace (2010)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">RCT</td><td class="cell">Multiple solid</td><td class="cell">Only grade P3 reported</td><td class="cell">Baseline</td><td class="cell">TNSc</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Every cycle for 3 cycles</td><td class="cell">NPS</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">1 mo after chemo end</td><td class="empty"></td></tr><tr><td class="cell">Planting (1999)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Controlled trial</td><td class="cell">Multiple solid</td><td class="cell">Grade I (5/5)</td><td class="cell">Baseline</td><td class="cell">NCI-CTC</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Cycle 3, 6</td><td class="cell">NES</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">3 mo after chemo end</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">(Longer follow-up but no denominator info)</td><td class="empty"></td></tr><tr><td class="cell">Van der Hoop (1999)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Controlled trial</td><td class="cell">Gynecological</td><td class="cell">Mean vibration threshold</td><td class="cell">Baseline</td><td class="cell">NES</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Cycles 2, 4, 6</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">End of chemo</td><td class="empty"></td></tr></table></body></html>